speb/financial-data huggingface dataset:
HCSG balance_sheet (quarterly, 2025-09-30) — Income Tax Payable: 0.00
HCSG income_statement (quarterly, 2025-09-30) — Interest Expense: 393000.00
HCSG income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 393000.00
HCSG balance_sheet (quarterly, 2025-09-30) — Inventory: 17202000.00
HCSG balance_sheet (quarterly, 2025-09-30) — Invested Capital: 496002000.00
HCSG cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -2746000.00
HCSG balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 6217000.00
HCSG balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 6217000.00
HCSG balance_sheet (quarterly, 2025-09-30) — Machinery Furniture Equipment: 9212000.00
HCSG cash_flow (quarterly, 2025-09-30) — Net Business Purchase And Sale: 0.00
HCSG cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: -27271000.00
HCSG income_statement (quarterly, 2025-09-30) — Net Income: 42953000.00
HCSG income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 42953000.00
HCSG income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 42953000.00
HCSG income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 42953000.00
HCSG income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 42953000.00
HCSG cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 42953000.00
HCSG income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 42953000.00
HCSG income_statement (quarterly, 2025-09-30) — Net Interest Income: -393000.00
HCSG cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: -1420000.00
HCSG income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -393000.00
HCSG cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: 0.00
HCSG balance_sheet (quarterly, 2025-09-30) — Net PPE: 26927000.00
HCSG cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -1326000.00
HCSG balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 408329000.00
HCSG balance_sheet (quarterly, 2025-09-30) — Non Current Accrued Expenses: 49138000.00
HCSG balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Assets: 77200000.00
HCSG balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 55648000.00
HCSG balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Assets: 21809000.00
HCSG balance_sheet (quarterly, 2025-09-30) — Non Current Note Receivables: 28351000.00
HCSG income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 53610000.00
HCSG income_statement (quarterly, 2025-09-30) — Normalized Income: 36863000.00
HCSG balance_sheet (quarterly, 2025-09-30) — Notes Receivable: 25406000.00
HCSG cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 71293000.00
HCSG cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: 4857000.00
HCSG income_statement (quarterly, 2025-09-30) — Operating Income: 49581000.00
HCSG income_statement (quarterly, 2025-09-30) — Operating Revenue: 464338000.00
HCSG balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 70671000.00
HCSG balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 12921000.00
HCSG balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 1129000.00
HCSG income_statement (quarterly, 2025-09-30) — Other Income Expense: 8120000.00
HCSG balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 7614000.00
HCSG balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 3515000.00
HCSG balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 1650000.00
HCSG balance_sheet (quarterly, 2025-09-30) — Other Properties: 49235000.00
HCSG balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 53073000.00
HCSG balance_sheet (quarterly, 2025-09-30) — Payables: 81715000.00
HCSG balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 167239000.00
HCSG balance_sheet (quarterly, 2025-09-30) — Prepaid Assets: 13515000.00
HCSG income_statement (quarterly, 2025-09-30) — Pretax Income: 57308000.00
HCSG cash_flow (quarterly, 2025-09-30) — Provisionand Write Offof Assets: 5631000.00
HCSG cash_flow (quarterly, 2025-09-30) — Purchase Of Business: 0.00
HCSG cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: -9273000.00
HCSG cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -1336000.00
HCSG balance_sheet (quarterly, 2025-09-30) — Receivables: 329489000.00
HCSG income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 367933000.00
HCSG income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 4029000.00
HCSG cash_flow (quarterly, 2025-09-30) — Repurchase Of Capital Stock: -27271000.00
HCSG balance_sheet (quarterly, 2025-09-30) — Restricted Cash: 30045000.00
HCSG balance_sheet (quarterly, 2025-09-30) — Retained Earnings: 252424000.00
HCSG cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 7853000.00
HCSG cash_flow (quarterly, 2025-09-30) — Sale Of PPE: 10000.00
HCSG income_statement (quarterly, 2025-09-30) — Selling General And Administration: 46824000.00
HCSG balance_sheet (quarterly, 2025-09-30) — Share Issued: 76821000.00
HCSG cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 2602000.00
HCSG balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 496002000.00
HCSG balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 408329000.00
HCSG income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 2030000.00
HCSG income_statement (quarterly, 2025-09-30) — Tax Provision: 14355000.00
HCSG income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.25
HCSG balance_sheet (quarterly, 2025-09-30) — Taxes Receivable: 15562000.00
HCSG balance_sheet (quarterly, 2025-09-30) — Total Assets: 804299000.00
HCSG balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 496002000.00
HCSG balance_sheet (quarterly, 2025-09-30) — Total Debt: 13859000.00
HCSG balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 496002000.00
HCSG income_statement (quarterly, 2025-09-30) — Total Expenses: 414757000.00
HCSG balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 308297000.00
HCSG balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 223666000.00
HCSG balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 112653000.00
HCSG balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 0.00
HCSG income_statement (quarterly, 2025-09-30) — Total Unusual Items: 8120000.00
HCSG income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: 8120000.00
HCSG balance_sheet (quarterly, 2025-09-30) — Treasury Shares Number: 6150000.00
HCSG balance_sheet (quarterly, 2025-09-30) — Treasury Stock: 82187000.00
HCSG cash_flow (quarterly, 2025-09-30) — Unrealized Gain Loss On Investment Securities: -3731000.00
HCSG balance_sheet (quarterly, 2025-09-30) — Working Capital: 384989000.00
HCSG income_statement (annual, 2025-12-31) — +Operating Expense: 183605000.00
HCSG income_statement (quarterly, 2025-12-31) — +Operating Expense: 45834000.00
HCSG income_statement (annual, 2025-12-31) — +Total Revenue: 1837173000.00
HCSG income_statement (quarterly, 2025-12-31) — +Total Revenue: 466682000.00
HCSG balance_sheet (annual, 2025-12-31) — Accounts Payable: 77382000.00
HCSG balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 77382000.00
HCSG balance_sheet (annual, 2025-12-31) — Accounts Receivable: 281303000.00
HCSG balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 281303000.00
HCSG balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -32248000.00
HCSG balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -32248000.00
HCSG balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 327956000.00
HCSG balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 327956000.00
HCSG balance_sheet (annual, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -119305000.00
HCSG balance_sheet (quarterly, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -119305000.00
HCSG cash_flow (annual, 2025-12-31) — Amortization Of Securities: 295000.00
HCSG cash_flow (quarterly, 2025-12-31) — Amortization Of Securities: -64000.00
HCSG income_statement (annual, 2025-12-31) — Basic Average Shares: 72380000.00
HCSG income_statement (quarterly, 2025-12-31) — Basic Average Shares: 70483000.00
HCSG income_statement (annual, 2025-12-31) — Basic EPS: 0.82
HCSG income_statement (quarterly, 2025-12-31) — Basic EPS: 0.44
HCSG cash_flow (annual, 2025-12-31) — Beginning Cash Position: 60131000.00
HCSG cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 124420000.00
HCSG cash_flow (annual, 2025-12-31) — Capital Expenditure: -5818000.00
HCSG cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -1380000.00
HCSG balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 9659000.00
HCSG balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 9659000.00
HCSG balance_sheet (annual, 2025-12-31) — Capital Stock: 768000.00
HCSG balance_sheet (quarterly, 2025-12-31) — Capital Stock: 768000.00
HCSG balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 125189000.00
HCSG balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 125189000.00
HCSG balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 167963000.00
HCSG balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 167963000.00
HCSG cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: -63330000.00
HCSG cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -19604000.00
HCSG cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -11003000.00
HCSG cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: 8563000.00
HCSG cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 144968000.00
HCSG cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 17387000.00
HCSG cash_flow (annual, 2025-12-31) — Change In Account Payable: -12064000.00
HCSG cash_flow (quarterly, 2025-12-31) — Change In Account Payable: -6754000.00
HCSG cash_flow (annual, 2025-12-31) — Change In Accrued Expense: -25665000.00
HCSG cash_flow (quarterly, 2025-12-31) — Change In Accrued Expense: -21416000.00
HCSG cash_flow (annual, 2025-12-31) — Change In Income Tax Payable: -30637000.00
HCSG cash_flow (annual, 2025-12-31) — Change In Inventory: -48000.00
HCSG cash_flow (quarterly, 2025-12-31) — Change In Inventory: 405000.00
HCSG cash_flow (annual, 2025-12-31) — Change In Other Working Capital: 20016000.00
HCSG cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: 24318000.00
HCSG cash_flow (annual, 2025-12-31) — Change In Payable: -42701000.00
HCSG cash_flow (quarterly, 2025-12-31) — Change In Payable: -37391000.00
HCSG cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: -68366000.00
HCSG cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: -58807000.00
HCSG cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: 2623000.00
HCSG cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: 6226000.00
HCSG cash_flow (annual, 2025-12-31) — Change In Receivables: 5227000.00
HCSG cash_flow (quarterly, 2025-12-31) — Change In Receivables: -28000.00
HCSG cash_flow (annual, 2025-12-31) — Change In Tax Payable: -30637000.00
HCSG cash_flow (annual, 2025-12-31) — Change In Working Capital: -40548000.00
HCSG cash_flow (quarterly, 2025-12-31) — Change In Working Capital: -27502000.00
HCSG cash_flow (annual, 2025-12-31) — Changes In Cash: 70635000.00
HCSG cash_flow (quarterly, 2025-12-31) — Changes In Cash: 6346000.00
HCSG balance_sheet (annual, 2025-12-31) — Common Stock: 768000.00
HCSG balance_sheet (quarterly, 2025-12-31) — Common Stock: 768000.00
HCSG balance_sheet (annual, 2025-12-31) — Common Stock Equity: 510210000.00
HCSG balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 510210000.00
HCSG cash_flow (annual, 2025-12-31) — Common Stock Payments: -61586000.00
HCSG cash_flow (quarterly, 2025-12-31) — Common Stock Payments: -19604000.00
HCSG income_statement (annual, 2025-12-31) — Cost Of Revenue: 1597768000.00
HCSG income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 394611000.00
HCSG balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 92993000.00
HCSG balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 92993000.00
HCSG balance_sheet (annual, 2025-12-31) — Current Assets: 576415000.00
HCSG balance_sheet (quarterly, 2025-12-31) — Current Assets: 576415000.00
HCSG balance_sheet (annual, 2025-12-31) — Current Liabilities: 170375000.00
HCSG balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 170375000.00
HCSG cash_flow (annual, 2025-12-31) — Deferred Income Tax: 19202000.00
HCSG cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: 3263000.00
HCSG cash_flow (annual, 2025-12-31) — Deferred Tax: 19202000.00
HCSG cash_flow (quarterly, 2025-12-31) — Deferred Tax: 3263000.00
HCSG cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 16778000.00
HCSG cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 3870000.00
HCSG cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 16778000.00
HCSG cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 3870000.00
HCSG income_statement (annual, 2025-12-31) — Diluted Average Shares: 73032000.00
HCSG income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 71635000.00
HCSG income_statement (annual, 2025-12-31) — Diluted EPS: 0.81
HCSG income_statement (quarterly, 2025-12-31) — Diluted EPS: 0.44
HCSG income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 59059000.00
HCSG income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 31244000.00
HCSG income_statement (annual, 2025-12-31) — EBIT: 69446000.00
HCSG income_statement (quarterly, 2025-12-31) — EBIT: 28926000.00
HCSG income_statement (annual, 2025-12-31) — EBITDA: 86224000.00
HCSG income_statement (quarterly, 2025-12-31) — EBITDA: 32796000.00
HCSG cash_flow (annual, 2025-12-31) — Earnings Losses From Equity Investments: 2386000.00
HCSG cash_flow (quarterly, 2025-12-31) — Earnings Losses From Equity Investments: 0.00
HCSG cash_flow (annual, 2025-12-31) — End Cash Position: 130766000.00
HCSG cash_flow (quarterly, 2025-12-31) — End Cash Position: 130766000.00
HCSG cash_flow (annual, 2025-12-31) — Financing Cash Flow: -63330000.00
HCSG cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -19604000.00
HCSG cash_flow (annual, 2025-12-31) — Free Cash Flow: 139150000.00
HCSG cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 16007000.00
HCSG cash_flow (annual, 2025-12-31) — Gain Loss On Sale Of PPE: 422000.00
HCSG cash_flow (quarterly, 2025-12-31) — Gain Loss On Sale Of PPE: 169000.00
HCSG income_statement (annual, 2025-12-31) — Gain On Sale Of Security: 13646000.00
HCSG income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: 2689000.00
HCSG balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -448000.00
HCSG balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -448000.00
HCSG balance_sheet (annual, 2025-12-31) — Goodwill: 79797000.00
HCSG balance_sheet (quarterly, 2025-12-31) — Goodwill: 79797000.00
HCSG balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 86761000.00
HCSG balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 86761000.00
HCSG balance_sheet (annual, 2025-12-31) — Gross Accounts Receivable: 400608000.00
HCSG balance_sheet (quarterly, 2025-12-31) — Gross Accounts Receivable: 400608000.00
HCSG balance_sheet (annual, 2025-12-31) — Gross PPE: 59834000.00
HCSG balance_sheet (quarterly, 2025-12-31) — Gross PPE: 59834000.00
HCSG income_statement (annual, 2025-12-31) — Gross Profit: 239405000.00
HCSG income_statement (quarterly, 2025-12-31) — Gross Profit: 72071000.00
HCSG cash_flow (annual, 2025-12-31) — Income Tax Paid Supplemental Data: 20387000.00
HCSG balance_sheet (annual, 2025-12-31) — Income Tax Payable: 0.00
HCSG balance_sheet (quarterly, 2025-12-31) — Income Tax Payable: 0.00
HCSG income_statement (annual, 2025-12-31) — Interest Expense: 1580000.00
HCSG income_statement (quarterly, 2025-12-31) — Interest Expense: 374000.00
HCSG income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 1580000.00
HCSG income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 374000.00
HCSG cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 1680000.00
HCSG balance_sheet (annual, 2025-12-31) — Inventory: 16797000.00
HCSG balance_sheet (quarterly, 2025-12-31) — Inventory: 16797000.00
HCSG balance_sheet (annual, 2025-12-31) — Invested Capital: 510210000.00
HCSG balance_sheet (quarterly, 2025-12-31) — Invested Capital: 510210000.00
HCSG cash_flow (annual, 2025-12-31) — Investing Cash Flow: -11003000.00
HCSG cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: 8563000.00
HCSG balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 9659000.00
HCSG balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 9659000.00
HCSG balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 9659000.00
HCSG balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 9659000.00
HCSG balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 9185000.00
HCSG balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 9185000.00
HCSG cash_flow (annual, 2025-12-31) — Net Business Purchase And Sale: -7153000.00
HCSG cash_flow (quarterly, 2025-12-31) — Net Business Purchase And Sale: 134000.00
HCSG cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: -61586000.00
HCSG cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: -19604000.00
HCSG income_statement (annual, 2025-12-31) — Net Income: 59059000.00
HCSG income_statement (quarterly, 2025-12-31) — Net Income: 31244000.00
HCSG income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 59059000.00
HCSG income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 31244000.00
HCSG income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 59059000.00
HCSG income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 31244000.00
HCSG income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 59059000.00
HCSG income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 31244000.00
HCSG income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 59059000.00
HCSG income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 31244000.00
HCSG cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 59059000.00
HCSG cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 31244000.00
HCSG income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 59059000.00
HCSG income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 31244000.00
HCSG income_statement (annual, 2025-12-31) — Net Interest Income: -1580000.00
HCSG income_statement (quarterly, 2025-12-31) — Net Interest Income: -374000.00
HCSG cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: 1863000.00
HCSG cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: 9790000.00
HCSG cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: 0.00
HCSG income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -1580000.00
HCSG income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -374000.00
HCSG cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -1744000.00
HCSG cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: 0.00
HCSG balance_sheet (annual, 2025-12-31) — Net PPE: 27586000.00
HCSG balance_sheet (quarterly, 2025-12-31) — Net PPE: 27586000.00
HCSG cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -5713000.00
HCSG cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -1361000.00
HCSG cash_flow (annual, 2025-12-31) — Net Short Term Debt Issuance: 0.00
HCSG balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 423449000.00
HCSG balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 423449000.00
HCSG balance_sheet (annual, 2025-12-31) — Non Current Accrued Expenses: 46142000.00
HCSG balance_sheet (quarterly, 2025-12-31) — Non Current Accrued Expenses: 46142000.00
HCSG balance_sheet (annual, 2025-12-31) — Non Current Deferred Assets: 74381000.00
HCSG balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Assets: 74381000.00
HCSG balance_sheet (annual, 2025-12-31) — Non Current Deferred Liabilities: 56276000.00
HCSG balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 56276000.00
HCSG balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Assets: 18472000.00
HCSG balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Assets: 18472000.00
HCSG balance_sheet (annual, 2025-12-31) — Non Current Note Receivables: 25209000.00
HCSG balance_sheet (quarterly, 2025-12-31) — Non Current Note Receivables: 25209000.00
HCSG income_statement (annual, 2025-12-31) — Normalized EBITDA: 72578000.00
HCSG income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 30107000.00
HCSG income_statement (annual, 2025-12-31) — Normalized Income: 47186980.00
HCSG income_statement (quarterly, 2025-12-31) — Normalized Income: 29119690.00
HCSG balance_sheet (annual, 2025-12-31) — Notes Receivable: 31243000.00
HCSG balance_sheet (quarterly, 2025-12-31) — Notes Receivable: 31243000.00
HCSG cash_flow (annual, 2025-12-31) — Operating Cash Flow: 144968000.00
HCSG cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 17387000.00
HCSG cash_flow (annual, 2025-12-31) — Operating Gains Losses: 2808000.00
HCSG cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: 169000.00
HCSG income_statement (annual, 2025-12-31) — Operating Income: 55800000.00
HCSG income_statement (quarterly, 2025-12-31) — Operating Income: 26237000.00
HCSG income_statement (annual, 2025-12-31) — Operating Revenue: 1837173000.00
HCSG income_statement (quarterly, 2025-12-31) — Operating Revenue: 466682000.00
HCSG balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 69596000.00
HCSG balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 69596000.00
HCSG balance_sheet (annual, 2025-12-31) — Other Current Assets: 20934000.00
HCSG balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 20934000.00
HCSG income_statement (annual, 2025-12-31) — Other Income Expense: 13646000.00
HCSG income_statement (quarterly, 2025-12-31) — Other Income Expense: 2689000.00
HCSG balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 6964000.00
HCSG balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 6964000.00
HCSG cash_flow (annual, 2025-12-31) — Other Non Cash Items: -384000.00
HCSG balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 3901000.00
HCSG balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 3901000.00
HCSG balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 1591000.00
HCSG balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 1591000.00
HCSG balance_sheet (annual, 2025-12-31) — Other Properties: 50649000.00
HCSG balance_sheet (quarterly, 2025-12-31) — Other Properties: 50649000.00
HCSG balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 42774000.00
HCSG balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 42774000.00
HCSG balance_sheet (annual, 2025-12-31) — Payables: 77382000.00
HCSG balance_sheet (quarterly, 2025-12-31) — Payables: 77382000.00
HCSG balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 170375000.00
HCSG balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 170375000.00
HCSG income_statement (annual, 2025-12-31) — Pretax Income: 67866000.00
HCSG income_statement (quarterly, 2025-12-31) — Pretax Income: 28552000.00
HCSG cash_flow (annual, 2025-12-31) — Provisionand Write Offof Assets: 83079000.00
HCSG cash_flow (quarterly, 2025-12-31) — Provisionand Write Offof Assets: 4067000.00
HCSG cash_flow (annual, 2025-12-31) — Purchase Of Business: -7153000.00
HCSG cash_flow (quarterly, 2025-12-31) — Purchase Of Business: 134000.00
HCSG cash_flow (annual, 2025-12-31) — Purchase Of Investment: -21342000.00
HCSG cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: -5333000.00
HCSG cash_flow (annual, 2025-12-31) — Purchase Of PPE: -5818000.00
HCSG cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -1380000.00
HCSG balance_sheet (annual, 2025-12-31) — Receivables: 334792000.00
HCSG balance_sheet (quarterly, 2025-12-31) — Receivables: 334792000.00
HCSG income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 1597768000.00
HCSG income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 394611000.00
HCSG income_statement (annual, 2025-12-31) — Reconciled Depreciation: 16778000.00
HCSG income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 3870000.00
HCSG cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: -61586000.00
HCSG cash_flow (quarterly, 2025-12-31) — Repurchase Of Capital Stock: -19604000.00
HCSG balance_sheet (annual, 2025-12-31) — Restricted Cash: 35929000.00
HCSG balance_sheet (quarterly, 2025-12-31) — Restricted Cash: 35929000.00
HCSG balance_sheet (annual, 2025-12-31) — Retained Earnings: 283668000.00
HCSG balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 283668000.00
HCSG cash_flow (annual, 2025-12-31) — Sale Of Investment: 23205000.00
HCSG cash_flow (quarterly, 2025-12-31) — Sale Of Investment: 15123000.00
HCSG cash_flow (annual, 2025-12-31) — Sale Of PPE: 105000.00
HCSG cash_flow (quarterly, 2025-12-31) — Sale Of PPE: 19000.00
HCSG income_statement (annual, 2025-12-31) — Selling General And Administration: 183605000.00
HCSG income_statement (quarterly, 2025-12-31) — Selling General And Administration: 45834000.00
HCSG balance_sheet (annual, 2025-12-31) — Share Issued: 76821000.00
HCSG balance_sheet (quarterly, 2025-12-31) — Share Issued: 76821000.00
HCSG cash_flow (annual, 2025-12-31) — Stock Based Compensation: 12005000.00
HCSG cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 3124000.00
HCSG balance_sheet (annual, 2025-12-31) — Stockholders Equity: 510210000.00
HCSG balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 510210000.00
HCSG balance_sheet (annual, 2025-12-31) — Tangible Book Value: 423449000.00
HCSG balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 423449000.00
HCSG income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 1773980.00
HCSG income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 564690.00
HCSG income_statement (annual, 2025-12-31) — Tax Provision: 8807000.00
HCSG income_statement (quarterly, 2025-12-31) — Tax Provision: -2692000.00
HCSG income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.13
HCSG income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.21
HCSG balance_sheet (annual, 2025-12-31) — Taxes Receivable: 22246000.00
HCSG balance_sheet (quarterly, 2025-12-31) — Taxes Receivable: 22246000.00
HCSG balance_sheet (annual, 2025-12-31) — Total Assets: 794253000.00
HCSG balance_sheet (quarterly, 2025-12-31) — Total Assets: 794253000.00
HCSG balance_sheet (annual, 2025-12-31) — Total Capitalization: 510210000.00
HCSG balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 510210000.00
HCSG balance_sheet (annual, 2025-12-31) — Total Debt: 9659000.00
HCSG balance_sheet (quarterly, 2025-12-31) — Total Debt: 9659000.00
HCSG balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 510210000.00
HCSG balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 510210000.00
HCSG income_statement (annual, 2025-12-31) — Total Expenses: 1781373000.00
HCSG income_statement (quarterly, 2025-12-31) — Total Expenses: 440445000.00
HCSG balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 284043000.00
HCSG balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 284043000.00
HCSG balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 217838000.00
HCSG balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 217838000.00
HCSG balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 113668000.00
HCSG balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 113668000.00
HCSG balance_sheet (annual, 2025-12-31) — Total Tax Payable: 0.00
HCSG balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 0.00
HCSG income_statement (annual, 2025-12-31) — Total Unusual Items: 13646000.00
HCSG income_statement (quarterly, 2025-12-31) — Total Unusual Items: 2689000.00
HCSG income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: 13646000.00
HCSG income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: 2689000.00
HCSG balance_sheet (annual, 2025-12-31) — Treasury Shares Number: 7225000.00
HCSG balance_sheet (quarterly, 2025-12-31) — Treasury Shares Number: 7225000.00
HCSG balance_sheet (annual, 2025-12-31) — Treasury Stock: 101734000.00
HCSG balance_sheet (quarterly, 2025-12-31) — Treasury Stock: 101734000.00
HCSG cash_flow (annual, 2025-12-31) — Unrealized Gain Loss On Investment Securities: -7326000.00
HCSG cash_flow (quarterly, 2025-12-31) — Unrealized Gain Loss On Investment Securities: -400000.00
HCSG balance_sheet (annual, 2025-12-31) — Working Capital: 406040000.00
HCSG balance_sheet (quarterly, 2025-12-31) — Working Capital: 406040000.00
HCSG income_statement (quarterly, 2026-03-31) — +Operating Expense: 43567000.00
HCSG income_statement (quarterly, 2026-03-31) — +Total Revenue: 462766000.00
HCSG balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 83124000.00
HCSG balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 299443000.00
HCSG balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -32258000.00
HCSG balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 328745000.00
HCSG balance_sheet (quarterly, 2026-03-31) — Allowance For Doubtful Accounts Receivable: -120089000.00
HCSG cash_flow (quarterly, 2026-03-31) — Amortization Of Securities: 48000.00
HCSG income_statement (quarterly, 2026-03-31) — Basic Average Shares: 69860000.00
HCSG income_statement (quarterly, 2026-03-31) — Basic EPS: 0.37
HCSG cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 130766000.00
HCSG cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -1398000.00
HCSG balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 14654000.00
HCSG balance_sheet (quarterly, 2026-03-31) — Capital Stock: 773000.00
HCSG balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 136172000.00
HCSG balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 178614000.00
HCSG cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -26678000.00
HCSG cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -11549000.00
HCSG cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: 43730000.00
HCSG cash_flow (quarterly, 2026-03-31) — Change In Account Payable: 4490000.00
HCSG cash_flow (quarterly, 2026-03-31) — Change In Accrued Expense: 16109000.00
HCSG cash_flow (quarterly, 2026-03-31) — Change In Inventory: 906000.00
HCSG cash_flow (quarterly, 2026-03-31) — Change In Other Current Liabilities: 0.00
HCSG cash_flow (quarterly, 2026-03-31) — Change In Other Working Capital: 6448000.00
HCSG cash_flow (quarterly, 2026-03-31) — Change In Payable: 4490000.00
HCSG cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: 20599000.00
HCSG cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: -7800000.00
HCSG cash_flow (quarterly, 2026-03-31) — Change In Receivables: -15166000.00
HCSG cash_flow (quarterly, 2026-03-31) — Change In Working Capital: 4987000.00
HCSG cash_flow (quarterly, 2026-03-31) — Changes In Cash: 5503000.00
HCSG balance_sheet (quarterly, 2026-03-31) — Common Stock: 773000.00
HCSG balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 513766000.00
HCSG cash_flow (quarterly, 2026-03-31) — Common Stock Payments: -23964000.00
HCSG income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 386932000.00
HCSG balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 81409000.00
HCSG balance_sheet (quarterly, 2026-03-31) — Current Assets: 601230000.00
HCSG balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 5291000.00
HCSG balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 5291000.00
HCSG balance_sheet (quarterly, 2026-03-31) — Current Deferred Liabilities: 22300000.00
HCSG balance_sheet (quarterly, 2026-03-31) — Current Deferred Revenue: 8003000.00
HCSG balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 193366000.00
HCSG cash_flow (quarterly, 2026-03-31) — Deferred Income Tax: 607000.00
HCSG cash_flow (quarterly, 2026-03-31) — Deferred Tax: 607000.00
HCSG cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 3806000.00
HCSG cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 3806000.00
HCSG income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 71049000.00
HCSG income_statement (quarterly, 2026-03-31) — Diluted EPS: 0.37
HCSG income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 26060000.00
HCSG income_statement (quarterly, 2026-03-31) — EBIT: 34906000.00
HCSG income_statement (quarterly, 2026-03-31) — EBITDA: 38712000.00
HCSG cash_flow (quarterly, 2026-03-31) — Earnings Losses From Equity Investments: 0.00
HCSG cash_flow (quarterly, 2026-03-31) — End Cash Position: 136269000.00
HCSG cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -26678000.00
HCSG cash_flow (quarterly, 2026-03-31) — Free Cash Flow: 42332000.00
HCSG cash_flow (quarterly, 2026-03-31) — Gain Loss On Sale Of PPE: 91000.00
HCSG income_statement (quarterly, 2026-03-31) — Gain On Sale Of Security: 2639000.00
HCSG balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: -835000.00
HCSG balance_sheet (quarterly, 2026-03-31) — Goodwill: 79797000.00
HCSG balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 86112000.00
HCSG balance_sheet (quarterly, 2026-03-31) — Gross Accounts Receivable: 419532000.00
HCSG balance_sheet (quarterly, 2026-03-31) — Gross PPE: 59290000.00
HCSG income_statement (quarterly, 2026-03-31) — Gross Profit: 75834000.00
HCSG income_statement (quarterly, 2026-03-31) — Interest Expense: 365000.00
HCSG income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 365000.00
HCSG balance_sheet (quarterly, 2026-03-31) — Inventory: 15891000.00
HCSG balance_sheet (quarterly, 2026-03-31) — Invested Capital: 513766000.00
HCSG cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -11549000.00
HCSG balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 9363000.00
HCSG balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 9363000.00
HCSG balance_sheet (quarterly, 2026-03-31) — Machinery Furniture Equipment: 9466000.00
HCSG cash_flow (quarterly, 2026-03-31) — Net Business Purchase And Sale: 0.00
HCSG cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: -23964000.00
HCSG income_statement (quarterly, 2026-03-31) — Net Income: 26060000.00
HCSG income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 26060000.00
HCSG income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 26060000.00
HCSG income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 26060000.00
HCSG income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 26060000.00
HCSG cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 26060000.00
HCSG income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 26060000.00
HCSG income_statement (quarterly, 2026-03-31) — Net Interest Income: -365000.00
HCSG cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: -10206000.00
HCSG income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -365000.00
HCSG cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: -4162000.00
HCSG balance_sheet (quarterly, 2026-03-31) — Net PPE: 27032000.00
HCSG cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -1343000.00
HCSG balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 427654000.00
HCSG balance_sheet (quarterly, 2026-03-31) — Non Current Accrued Expenses: 43822000.00
HCSG balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Assets: 70962000.00
HCSG balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 52934000.00
HCSG balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 17967000.00
HCSG balance_sheet (quarterly, 2026-03-31) — Non Current Note Receivables: 20628000.00
HCSG income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 36073000.00
HCSG income_statement (quarterly, 2026-03-31) — Normalized Income: 24068965.00
HCSG balance_sheet (quarterly, 2026-03-31) — Notes Receivable: 29068000.00
HCSG cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 43730000.00
HCSG cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: 91000.00
HCSG income_statement (quarterly, 2026-03-31) — Operating Income: 32267000.00
HCSG income_statement (quarterly, 2026-03-31) — Operating Revenue: 462766000.00
HCSG balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 68931000.00
HCSG balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 27992000.00
HCSG balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 1242000.00
HCSG income_statement (quarterly, 2026-03-31) — Other Income Expense: 2639000.00
HCSG balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 6315000.00
HCSG balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 8881000.00
HCSG balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 1594000.00
HCSG balance_sheet (quarterly, 2026-03-31) — Other Properties: 49824000.00
HCSG balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 42442000.00
HCSG balance_sheet (quarterly, 2026-03-31) — Payables: 83124000.00
HCSG balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 164533000.00
HCSG income_statement (quarterly, 2026-03-31) — Pretax Income: 34541000.00
HCSG cash_flow (quarterly, 2026-03-31) — Proceeds From Stock Option Exercised: 1448000.00
HCSG cash_flow (quarterly, 2026-03-31) — Provisionand Write Offof Assets: 3784000.00
HCSG cash_flow (quarterly, 2026-03-31) — Purchase Of Business: 0.00
HCSG cash_flow (quarterly, 2026-03-31) — Purchase Of Investment: -11888000.00
HCSG cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -1398000.00
HCSG balance_sheet (quarterly, 2026-03-31) — Receivables: 342738000.00
HCSG income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 386932000.00
HCSG income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 3806000.00
HCSG cash_flow (quarterly, 2026-03-31) — Repurchase Of Capital Stock: -23964000.00
HCSG balance_sheet (quarterly, 2026-03-31) — Restricted Cash: 35995000.00
HCSG balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 309731000.00
HCSG cash_flow (quarterly, 2026-03-31) — Sale Of Investment: 1682000.00
HCSG cash_flow (quarterly, 2026-03-31) — Sale Of PPE: 55000.00
HCSG income_statement (quarterly, 2026-03-31) — Selling General And Administration: 43567000.00
HCSG balance_sheet (quarterly, 2026-03-31) — Share Issued: 77270000.00
HCSG cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 2764000.00
HCSG balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 513766000.00
HCSG balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 427654000.00
HCSG income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 647965.00
HCSG income_statement (quarterly, 2026-03-31) — Tax Provision: 8481000.00
HCSG income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.25
HCSG balance_sheet (quarterly, 2026-03-31) — Taxes Receivable: 14227000.00
HCSG balance_sheet (quarterly, 2026-03-31) — Total Assets: 814845000.00
HCSG balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 513766000.00
HCSG balance_sheet (quarterly, 2026-03-31) — Total Debt: 14654000.00
HCSG balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 513766000.00
HCSG income_statement (quarterly, 2026-03-31) — Total Expenses: 430499000.00
HCSG balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 301079000.00
HCSG balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 213615000.00
HCSG balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 107713000.00
HCSG income_statement (quarterly, 2026-03-31) — Total Unusual Items: 2639000.00
HCSG income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: 2639000.00
HCSG balance_sheet (quarterly, 2026-03-31) — Treasury Shares Number: 8339000.00
HCSG balance_sheet (quarterly, 2026-03-31) — Treasury Stock: 124648000.00
HCSG cash_flow (quarterly, 2026-03-31) — Unrealized Gain Loss On Investment Securities: 1583000.00
HCSG balance_sheet (quarterly, 2026-03-31) — Working Capital: 407864000.00
HCT.AX balance_sheet (annual, 2021-12-31) — Cash Equivalents: 700081.00
HCT.AX balance_sheet (annual, 2021-12-31) — Current Provisions: 34496.00
HCT.AX balance_sheet (annual, 2021-12-31) — Long Term Provisions: 275000.00
HCT.AX cash_flow (annual, 2021-12-31) — Net Intangibles Purchase And Sale: -3333.00
HCT.AX balance_sheet (annual, 2021-12-31) — Non Current Deferred Assets: 83166.00
HCT.AX balance_sheet (annual, 2021-12-31) — Non Current Deferred Taxes Assets: 83166.00
HCT.AX income_statement (annual, 2021-12-31) — Other Gand A: 197632.00
HCT.AX balance_sheet (annual, 2021-12-31) — Other Inventories: 461807.00
HCT.AX income_statement (annual, 2021-12-31) — Provision For Doubtful Accounts: 144515.00
HCT.AX cash_flow (annual, 2021-12-31) — Purchase Of Intangibles: -3333.00
HCT.AX cash_flow (annual, 2021-12-31) — Receiptsfrom Government Grants: 88979.00
HCT.AX cash_flow (annual, 2021-12-31) — Sale Of Investment: 91809.00
HCT.AX income_statement (annual, 2022-12-31) — +Operating Expense: 5660846.00
HCT.AX income_statement (annual, 2022-12-31) — +Total Revenue: 8241225.00
HCT.AX balance_sheet (annual, 2022-12-31) — Accounts Payable: 1128239.00
HCT.AX balance_sheet (annual, 2022-12-31) — Accounts Receivable: 3293464.00
HCT.AX balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -2242686.00
HCT.AX income_statement (annual, 2022-12-31) — Amortization: 15195.00
HCT.AX income_statement (annual, 2022-12-31) — Amortization Of Intangibles Income Statement: 15195.00
HCT.AX income_statement (annual, 2022-12-31) — Basic Average Shares: 279404038.00
HCT.AX income_statement (annual, 2022-12-31) — Basic EPS: -0.01
HCT.AX cash_flow (annual, 2022-12-31) — Beginning Cash Position: 1213093.00
HCT.AX cash_flow (annual, 2022-12-31) — Capital Expenditure: -136863.00
HCT.AX balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 279268.00
HCT.AX balance_sheet (annual, 2022-12-31) — Capital Stock: 21787478.00
HCT.AX balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 117528.00
HCT.AX balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 117528.00
HCT.AX balance_sheet (annual, 2022-12-31) — Cash Financial: 117528.00
HCT.AX cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: 186876.00
HCT.AX cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -163957.00
HCT.AX cash_flow (annual, 2022-12-31) — Cash Flowsfromusedin Operating Activities Direct: -1119196.00
HCT.AX cash_flow (annual, 2022-12-31) — Changes In Cash: -1096277.00
HCT.AX cash_flow (annual, 2022-12-31) — Classesof Cash Payments: -10053417.00
HCT.AX cash_flow (annual, 2022-12-31) — Classesof Cash Receiptsfrom Operating Activities: 9159180.00
HCT.AX balance_sheet (annual, 2022-12-31) — Common Stock: 21787478.00
HCT.AX balance_sheet (annual, 2022-12-31) — Common Stock Equity: 2829292.00
HCT.AX cash_flow (annual, 2022-12-31) — Common Stock Issuance: 80000.00
HCT.AX income_statement (annual, 2022-12-31) — Cost Of Revenue: 3997354.00
HCT.AX balance_sheet (annual, 2022-12-31) — Current Assets: 4066354.00
HCT.AX balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 27183.00
HCT.AX balance_sheet (annual, 2022-12-31) — Current Debt: 471221.00
HCT.AX balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 498404.00
HCT.AX balance_sheet (annual, 2022-12-31) — Current Deferred Assets: 68205.00
HCT.AX balance_sheet (annual, 2022-12-31) — Current Deferred Liabilities: 52851.00
HCT.AX balance_sheet (annual, 2022-12-31) — Current Deferred Revenue: 52851.00
HCT.AX balance_sheet (annual, 2022-12-31) — Current Deferred Taxes Assets: 68205.00
HCT.AX balance_sheet (annual, 2022-12-31) — Current Liabilities: 2954514.00
HCT.AX balance_sheet (annual, 2022-12-31) — Current Provisions: 40529.00
HCT.AX income_statement (annual, 2022-12-31) — Depreciation Amortization Depletion Income Statement: 273952.00
HCT.AX income_statement (annual, 2022-12-31) — Depreciation And Amortization In Income Statement: 273952.00
HCT.AX income_statement (annual, 2022-12-31) — Depreciation Income Statement: 258757.00
HCT.AX income_statement (annual, 2022-12-31) — Diluted Average Shares: 279404038.00
HCT.AX income_statement (annual, 2022-12-31) — Diluted EPS: -0.01
HCT.AX income_statement (annual, 2022-12-31) — EBIT: -1298214.00
HCT.AX income_statement (annual, 2022-12-31) — EBITDA: -1024262.00
HCT.AX cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: 711.00
HCT.AX cash_flow (annual, 2022-12-31) — End Cash Position: 117527.00
HCT.AX cash_flow (annual, 2022-12-31) — Financing Cash Flow: 186876.00
HCT.AX balance_sheet (annual, 2022-12-31) — Finished Goods: 811838.00
HCT.AX balance_sheet (annual, 2022-12-31) — Foreign Currency Translation Adjustments: -99952.00
HCT.AX cash_flow (annual, 2022-12-31) — Free Cash Flow: -1256059.00
HCT.AX balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: -99952.00
HCT.AX income_statement (annual, 2022-12-31) — General And Administrative Expense: 2885713.00
HCT.AX balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 104610.00
HCT.AX balance_sheet (annual, 2022-12-31) — Gross PPE: 3476931.00
HCT.AX income_statement (annual, 2022-12-31) — Gross Profit: 4243871.00
HCT.AX cash_flow (annual, 2022-12-31) — Income Tax Paid Supplemental Data: 159285.00
HCT.AX income_statement (annual, 2022-12-31) — Interest Expense: 66528.00
HCT.AX income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 66528.00
HCT.AX income_statement (annual, 2022-12-31) — Interest Income: 854.00
HCT.AX income_statement (annual, 2022-12-31) — Interest Income Non Operating: 854.00
HCT.AX cash_flow (annual, 2022-12-31) — Interest Paid Direct: -66528.00
HCT.AX cash_flow (annual, 2022-12-31) — Interest Paid Supplemental Data: 66528.00
HCT.AX cash_flow (annual, 2022-12-31) — Interest Received Direct: 854.00
HCT.AX balance_sheet (annual, 2022-12-31) — Inventory: 1411962.00
HCT.AX balance_sheet (annual, 2022-12-31) — Invested Capital: 3769941.00
HCT.AX cash_flow (annual, 2022-12-31) — Investing Cash Flow: -163957.00
HCT.AX cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 80000.00
HCT.AX cash_flow (annual, 2022-12-31) — Issuance Of Debt: 144016.00
HCT.AX balance_sheet (annual, 2022-12-31) — Land And Improvements: 1051694.00
HCT.AX balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 252085.00
HCT.AX balance_sheet (annual, 2022-12-31) — Long Term Debt: 469428.00
HCT.AX balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 721513.00
HCT.AX cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 144016.00
HCT.AX cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -3943332.00